主管:国家卫生健康委员会
主办:国家卫生健康委医院管理研究所
中国科技核心期刊(中国科技论文统计源期刊)
中国科学引文数据库(CSCD)核心库期刊
《中文核心期刊要目总览》核心期刊

中国护理管理 ›› 2024, Vol. 24 ›› Issue (7): 1053-1058.doi: 10.3969/j.issn.1672-1756.2024.07.018

• 循证护理 • 上一篇    下一篇

癌症患者免疫相关皮肤不良反应预防及管理的证据总结

张婷婷 彭娜娜 张晓菊 陆箴琦 陈凤珍   

  1. 复旦大学附属肿瘤医院护理部/复旦大学上海医学院肿瘤学系,200032 上海市
  • 出版日期:2024-07-15 发布日期:2024-07-15
  • 通讯作者: 陆箴琦,硕士,主任护师,E-mail:luzhenqi1972@163.com
  • 作者简介:张婷婷,硕士在读
  • 基金资助:
    国家自然科学基金青年科学基金项目(72004031)

Evidence summary for the prevention and management of immune-related cutaneous adverse events in cancer patients

ZHANG Tingting, PENG Nana, ZHANG Xiaoju, LU Zhenqi, CHEN Fengzhen   

  1. Department of Nursing, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China
  • Online:2024-07-15 Published:2024-07-15
  • Contact: E-mail:luzhenqi1972@163.com

摘要: 目的:系统检索、评价并提取总结国内外关于癌症患者免疫相关皮肤不良反应预防及管理的相关证据。方法:依据“6S”金字塔模型,自上而下系统检索相关网站和数据库中关于癌症患者免疫相关皮肤不良反应预防及管理的文献,检索时限为2013年1月1日至2023年12月31日。对纳入的文献进行质量评价后提取证据并整合。结果:共纳入16篇文献,其中指南7篇、临床决策1篇、专家共识6篇、系统评价2篇,从多学科团队、基线评估、皮肤日常管理、早期诊断、症状处理、随访监测、健康教育7个方面形成了28条证据。结论:本研究总结了癌症患者免疫相关皮肤不良反应预防及管理的相关证据,可以为临床医护人员制定皮肤不良反应管理策略提供参考,但对患者开展临床实践时仍需要结合临床实际情况和患者个体需求选择适宜的证据。

关键词: 癌症免疫治疗;免疫检查点抑制剂;皮肤不良反应;症状管理;证据总结;循证护理

Abstract: Objective: To retrieve, evaluate and summarize the latest evidence on the prevention and management for immune-related cutaneous adverse events in cancer patients. Methods: Based on the 6S pyramid model, literatures on the prevention and management of immune-related cutaneous adverse events in cancer patients were systematically searched. The retrieval period was from January 1, 2013 to December 31, 2023. Evidence was extracted and integrated after quality evaluation of the included studies. Results: A total of 16 articles were finally included, containing 7 guidelines, 1 clinical decision, 6 expert consensuses and 2 systematic reviews. In total, 28 pieces of evidence including 7 aspects were summarized, namely multidisciplinary team, baseline assessment, daily cutaneous management, early diagnosis, symptom management, follow-up monitoring, and health education. Conclusion: The study summarized the evidence for the prevention and management of immune-related cutaneous adverse events in cancer patients, which can provide a reference for clinicians to formulate reasonable management strategies. However, it is still necessary to choose appropriate evidence based on the actual clinical situation and patients' individual needs in clinical practice.

Key words: immunotherapy for cancer; immune checkpoint inhibitors; cutaneous adverse events; symptom management; evidence summary; evidence-based nursing

中图分类号:  R47;R197